The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study

The purpose of this study was to explore the effects of Xueshuan Xinmai tablets (XXMT) for the treatment of cognition, brain activation in the rehabilitation period of ischemic stroke patients. 28 adults patients, aged 50-80 years, in the rehabilitation period of ischemic stroke were divided into XX...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical and experimental medicine 2015-01, Vol.8 (5), p.7507-7516
Hauptverfasser: Wei, Dongfeng, Lv, Chenlong, Zhang, Junying, Peng, Dantao, Hu, Liangping, Zhang, Zhanjun, Wang, Yongyan
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 7516
container_issue 5
container_start_page 7507
container_title International journal of clinical and experimental medicine
container_volume 8
creator Wei, Dongfeng
Lv, Chenlong
Zhang, Junying
Peng, Dantao
Hu, Liangping
Zhang, Zhanjun
Wang, Yongyan
description The purpose of this study was to explore the effects of Xueshuan Xinmai tablets (XXMT) for the treatment of cognition, brain activation in the rehabilitation period of ischemic stroke patients. 28 adults patients, aged 50-80 years, in the rehabilitation period of ischemic stroke were divided into XXMT treatment group and placebo control group. Patients received 3 months treatment (oral 0.8 g, 3 times per day). Before and after treatment, all patients were evaluated by a series of neuropsychological tests followed by resting-state functional magnetic resonance imaging (fMRI). In the XXMT treatment group, the patients' episodic memory showed significant improvement. The resting-state fMRI analysis indicated that a significant decline in the fractional amplitude of low-frequency fluctuation value was observed in the bilateral middle cingulate gyrus. Yiqi Huoxue effect under XXMT administration has a favorable mediation on episodic memory, consequently suppresses the activation of the cingulate gyrus in the rehabilitation period of ischemic stroke patients.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4509239</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1700336031</sourcerecordid><originalsourceid>FETCH-LOGICAL-p266t-81503a2d7c1447e46404d0c9a6ed08be8bbac9e3c6c0e6253aaf4c375b5f9fa83</originalsourceid><addsrcrecordid>eNpVUctKxTAULKL4_gU5SzeFtEnT1oUg4uOCIojC3ZXT9NRG06Q26YX7H36wFa-iqzkww8xhZivaT0rB4qxkyfafey868P6VMZmkvNyN9lKZpklaiv3o46kjCB2NONAUtAJqW1IBXAvLiXw3oYWltj1qCFgbCh6chZ56N65B29dpBrQN1CNqC6iCXunwxcDgfIh9GN0bwYBBkw3-DBAGbVyAwaCi2oFydpYYQw20948L8GFq1kfRTovG0_EGD6Pn66uny9v47uFmcXlxFw-plCEukoxxTJtcJULkJKRgomGqREkNK2oq6hpVSVxJxUimGUdsheJ5Vmdt2WLBD6Pzb99hqntq1PziiKYaRt3juK4c6uo_Y3VXvbhVJTJWzk3OBqcbg9G9z3WFqtdekTFoyU2-SnLGOJeMJ7P05G_Wb8jPFPwTxfSK9g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1700336031</pqid></control><display><type>article</type><title>The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Wei, Dongfeng ; Lv, Chenlong ; Zhang, Junying ; Peng, Dantao ; Hu, Liangping ; Zhang, Zhanjun ; Wang, Yongyan</creator><creatorcontrib>Wei, Dongfeng ; Lv, Chenlong ; Zhang, Junying ; Peng, Dantao ; Hu, Liangping ; Zhang, Zhanjun ; Wang, Yongyan</creatorcontrib><description>The purpose of this study was to explore the effects of Xueshuan Xinmai tablets (XXMT) for the treatment of cognition, brain activation in the rehabilitation period of ischemic stroke patients. 28 adults patients, aged 50-80 years, in the rehabilitation period of ischemic stroke were divided into XXMT treatment group and placebo control group. Patients received 3 months treatment (oral 0.8 g, 3 times per day). Before and after treatment, all patients were evaluated by a series of neuropsychological tests followed by resting-state functional magnetic resonance imaging (fMRI). In the XXMT treatment group, the patients' episodic memory showed significant improvement. The resting-state fMRI analysis indicated that a significant decline in the fractional amplitude of low-frequency fluctuation value was observed in the bilateral middle cingulate gyrus. Yiqi Huoxue effect under XXMT administration has a favorable mediation on episodic memory, consequently suppresses the activation of the cingulate gyrus in the rehabilitation period of ischemic stroke patients.</description><identifier>ISSN: 1940-5901</identifier><identifier>EISSN: 1940-5901</identifier><identifier>PMID: 26221294</identifier><language>eng</language><publisher>United States: e-Century Publishing Corporation</publisher><subject>Original</subject><ispartof>International journal of clinical and experimental medicine, 2015-01, Vol.8 (5), p.7507-7516</ispartof><rights>IJCEM Copyright © 2015 2015</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509239/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4509239/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,728,781,785,886,53796,53798</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26221294$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wei, Dongfeng</creatorcontrib><creatorcontrib>Lv, Chenlong</creatorcontrib><creatorcontrib>Zhang, Junying</creatorcontrib><creatorcontrib>Peng, Dantao</creatorcontrib><creatorcontrib>Hu, Liangping</creatorcontrib><creatorcontrib>Zhang, Zhanjun</creatorcontrib><creatorcontrib>Wang, Yongyan</creatorcontrib><title>The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study</title><title>International journal of clinical and experimental medicine</title><addtitle>Int J Clin Exp Med</addtitle><description>The purpose of this study was to explore the effects of Xueshuan Xinmai tablets (XXMT) for the treatment of cognition, brain activation in the rehabilitation period of ischemic stroke patients. 28 adults patients, aged 50-80 years, in the rehabilitation period of ischemic stroke were divided into XXMT treatment group and placebo control group. Patients received 3 months treatment (oral 0.8 g, 3 times per day). Before and after treatment, all patients were evaluated by a series of neuropsychological tests followed by resting-state functional magnetic resonance imaging (fMRI). In the XXMT treatment group, the patients' episodic memory showed significant improvement. The resting-state fMRI analysis indicated that a significant decline in the fractional amplitude of low-frequency fluctuation value was observed in the bilateral middle cingulate gyrus. Yiqi Huoxue effect under XXMT administration has a favorable mediation on episodic memory, consequently suppresses the activation of the cingulate gyrus in the rehabilitation period of ischemic stroke patients.</description><subject>Original</subject><issn>1940-5901</issn><issn>1940-5901</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNpVUctKxTAULKL4_gU5SzeFtEnT1oUg4uOCIojC3ZXT9NRG06Q26YX7H36wFa-iqzkww8xhZivaT0rB4qxkyfafey868P6VMZmkvNyN9lKZpklaiv3o46kjCB2NONAUtAJqW1IBXAvLiXw3oYWltj1qCFgbCh6chZ56N65B29dpBrQN1CNqC6iCXunwxcDgfIh9GN0bwYBBkw3-DBAGbVyAwaCi2oFydpYYQw20948L8GFq1kfRTovG0_EGD6Pn66uny9v47uFmcXlxFw-plCEukoxxTJtcJULkJKRgomGqREkNK2oq6hpVSVxJxUimGUdsheJ5Vmdt2WLBD6Pzb99hqntq1PziiKYaRt3juK4c6uo_Y3VXvbhVJTJWzk3OBqcbg9G9z3WFqtdekTFoyU2-SnLGOJeMJ7P05G_Wb8jPFPwTxfSK9g</recordid><startdate>20150101</startdate><enddate>20150101</enddate><creator>Wei, Dongfeng</creator><creator>Lv, Chenlong</creator><creator>Zhang, Junying</creator><creator>Peng, Dantao</creator><creator>Hu, Liangping</creator><creator>Zhang, Zhanjun</creator><creator>Wang, Yongyan</creator><general>e-Century Publishing Corporation</general><scope>NPM</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20150101</creationdate><title>The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study</title><author>Wei, Dongfeng ; Lv, Chenlong ; Zhang, Junying ; Peng, Dantao ; Hu, Liangping ; Zhang, Zhanjun ; Wang, Yongyan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p266t-81503a2d7c1447e46404d0c9a6ed08be8bbac9e3c6c0e6253aaf4c375b5f9fa83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Original</topic><toplevel>online_resources</toplevel><creatorcontrib>Wei, Dongfeng</creatorcontrib><creatorcontrib>Lv, Chenlong</creatorcontrib><creatorcontrib>Zhang, Junying</creatorcontrib><creatorcontrib>Peng, Dantao</creatorcontrib><creatorcontrib>Hu, Liangping</creatorcontrib><creatorcontrib>Zhang, Zhanjun</creatorcontrib><creatorcontrib>Wang, Yongyan</creatorcontrib><collection>PubMed</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of clinical and experimental medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wei, Dongfeng</au><au>Lv, Chenlong</au><au>Zhang, Junying</au><au>Peng, Dantao</au><au>Hu, Liangping</au><au>Zhang, Zhanjun</au><au>Wang, Yongyan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study</atitle><jtitle>International journal of clinical and experimental medicine</jtitle><addtitle>Int J Clin Exp Med</addtitle><date>2015-01-01</date><risdate>2015</risdate><volume>8</volume><issue>5</issue><spage>7507</spage><epage>7516</epage><pages>7507-7516</pages><issn>1940-5901</issn><eissn>1940-5901</eissn><abstract>The purpose of this study was to explore the effects of Xueshuan Xinmai tablets (XXMT) for the treatment of cognition, brain activation in the rehabilitation period of ischemic stroke patients. 28 adults patients, aged 50-80 years, in the rehabilitation period of ischemic stroke were divided into XXMT treatment group and placebo control group. Patients received 3 months treatment (oral 0.8 g, 3 times per day). Before and after treatment, all patients were evaluated by a series of neuropsychological tests followed by resting-state functional magnetic resonance imaging (fMRI). In the XXMT treatment group, the patients' episodic memory showed significant improvement. The resting-state fMRI analysis indicated that a significant decline in the fractional amplitude of low-frequency fluctuation value was observed in the bilateral middle cingulate gyrus. Yiqi Huoxue effect under XXMT administration has a favorable mediation on episodic memory, consequently suppresses the activation of the cingulate gyrus in the rehabilitation period of ischemic stroke patients.</abstract><cop>United States</cop><pub>e-Century Publishing Corporation</pub><pmid>26221294</pmid><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1940-5901
ispartof International journal of clinical and experimental medicine, 2015-01, Vol.8 (5), p.7507-7516
issn 1940-5901
1940-5901
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4509239
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Original
title The therapeutic effect of Xueshuan Xinmai tablets on memory injury and brain activity in post-stroke patients: a pilot placebo controlled fMRI study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T21%3A34%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20therapeutic%20effect%20of%20Xueshuan%20Xinmai%20tablets%20on%20memory%20injury%20and%20brain%20activity%20in%20post-stroke%20patients:%20a%20pilot%20placebo%20controlled%20fMRI%20study&rft.jtitle=International%20journal%20of%20clinical%20and%20experimental%20medicine&rft.au=Wei,%20Dongfeng&rft.date=2015-01-01&rft.volume=8&rft.issue=5&rft.spage=7507&rft.epage=7516&rft.pages=7507-7516&rft.issn=1940-5901&rft.eissn=1940-5901&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E1700336031%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1700336031&rft_id=info:pmid/26221294&rfr_iscdi=true